# Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder

> **NCT01452061** · — · COMPLETED · sponsor: **Thomas W. Frazier, Ph.D** · enrollment: 456 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Attention Deficit/Hyperactivity Disorder
- Developmental Delay

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01452061
- **Lead sponsor:** Thomas W. Frazier, Ph.D
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2014-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452061, "Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01452061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*